Randomized Controlled Trial
. 2009 Sep 1;180(5):445-53. doi: 10.1164/rccm.200901-0076OC. Epub 2009 Jun 11. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial Silvio Cavuto, Fabio Romano Lutman, Giorgio Brambilla, Giuseppe Chiesa, Giovanni Ceresoli, Eliseo Passera, Enzo Angeli, Maurizio Chiarenza, Giuseppe Aranzulla, Umberto Cariboni, Valentina Errico, Francesco Inzirillo, Edoardo Bottoni, Emanuele Voulaz, Marco Alloisio, Anna Destro, Massimo Roncalli, Armando Santoro, Gianluigi Ravasi; DANTE Study GroupCollaborators, Affiliations
CollaboratorsItem in Clipboard
Randomized Controlled Trial
A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trialMaurizio Infante et al. Am J Respir Crit Care Med. 2009.
. 2009 Sep 1;180(5):445-53. doi: 10.1164/rccm.200901-0076OC. Epub 2009 Jun 11. Authors Maurizio Infante 1 , Silvio Cavuto, Fabio Romano Lutman, Giorgio Brambilla, Giuseppe Chiesa, Giovanni Ceresoli, Eliseo Passera, Enzo Angeli, Maurizio Chiarenza, Giuseppe Aranzulla, Umberto Cariboni, Valentina Errico, Francesco Inzirillo, Edoardo Bottoni, Emanuele Voulaz, Marco Alloisio, Anna Destro, Massimo Roncalli, Armando Santoro, Gianluigi Ravasi; DANTE Study Group CollaboratorsItem in Clipboard
AbstractRationale: Screening for lung cancer with modern imaging technology may decrease lung cancer mortality, but encouraging results have only been obtained in uncontrolled studies.
Objectives: To explore the effect of screening with low-dose spiral computed tomography (LDCT) on lung cancer mortality. Secondary endpoints are incidence, stage at diagnosis, and resectability.
Methods: Male subjects, aged 60 to 75 years, smokers of 20 or more pack-years, were randomized to screening with LDCT or control groups. All participants underwent a baseline, once-only chest X-ray and sputum cytology examination. Screening-arm subjects had LDCT upon accrual to be repeated every year for 4 years, whereas controls had a yearly medical examination only.
Measurements and main results: A total of 2,811 subjects were randomized and 2,472 were enrolled (LDCT, 1,276; control, 1,196). After a median follow-up of 33 months, lung cancer was detected in 60 (4.7%) patients receiving LDCT and 34 (2.8%) control subjects (P = 0.016). Resectability rates were similar in both groups. More patients with stage I disease were detected by LDCT (54 vs. 34%; P = 0.06) and fewer cases were detected in the screening arm due to intercurrent symptoms. However, the number of advanced lung cancer cases was the same as in the control arm. Twenty patients in the LDCT group (1.6%) and 20 controls (1.7%) died of lung cancer, whereas 26 and 25 died of other causes, respectively.
Conclusions: The mortality benefit from lung cancer screening by LDCT might be far smaller than anticipated.
Similar articlesInfante M, Cavuto S, Lutman FR, Passera E, Chiarenza M, Chiesa G, Brambilla G, Angeli E, Aranzulla G, Chiti A, Scorsetti M, Navarria P, Cavina R, Ciccarelli M, Roncalli M, Destro A, Bottoni E, Voulaz E, Errico V, Ferraroli G, Finocchiaro G, Toschi L, Santoro A, Alloisio M; DANTE Study Group. Infante M, et al. Am J Respir Crit Care Med. 2015 May 15;191(10):1166-75. doi: 10.1164/rccm.201408-1475OC. Am J Respir Crit Care Med. 2015. PMID: 25760561 Clinical Trial.
Infante M, Lutman FR, Cavuto S, Brambilla G, Chiesa G, Passera E, Angeli E, Chiarenza M, Aranzulla G, Cariboni U, Alloisio M, Incarbone M, Testori A, Destro A, Cappuzzo F, Roncalli M, Santoro A, Ravasi G; DANTE Study Group. Infante M, et al. Lung Cancer. 2008 Mar;59(3):355-63. doi: 10.1016/j.lungcan.2007.08.040. Epub 2007 Oct 23. Lung Cancer. 2008. PMID: 17936405 Clinical Trial.
Pastorino U, Rossi M, Rosato V, Marchianò A, Sverzellati N, Morosi C, Fabbri A, Galeone C, Negri E, Sozzi G, Pelosi G, La Vecchia C. Pastorino U, et al. Eur J Cancer Prev. 2012 May;21(3):308-15. doi: 10.1097/CEJ.0b013e328351e1b6. Eur J Cancer Prev. 2012. PMID: 22465911 Clinical Trial.
Aberle DR, Abtin F, Brown K. Aberle DR, et al. J Clin Oncol. 2013 Mar 10;31(8):1002-8. doi: 10.1200/JCO.2012.43.3110. Epub 2013 Feb 11. J Clin Oncol. 2013. PMID: 23401434 Free PMC article. Review.
Fu C, Liu Z, Zhu F, Li S, Jiang L. Fu C, et al. Clin Respir J. 2016 May;10(3):333-41. doi: 10.1111/crj.12222. Epub 2014 Nov 26. Clin Respir J. 2016. PMID: 25307063 Review.
Halpenny DF, Cunningham JD, Long NM, Sosa RE, Ginsberg MS. Halpenny DF, et al. J Thorac Oncol. 2016 Sep;11(9):1447-52. doi: 10.1016/j.jtho.2016.05.006. Epub 2016 May 17. J Thorac Oncol. 2016. PMID: 27223458 Free PMC article.
Patz EF Jr, Caporaso NE, Dubinett SM, Massion PP, Hirsch FR, Minna JD, Gatsonis C, Duan F, Adams A, Apgar C, Medina RM, Aberle DR. Patz EF Jr, et al. J Thorac Oncol. 2010 Oct;5(10):1502-6. doi: 10.1097/JTO.0b013e3181f1c634. J Thorac Oncol. 2010. PMID: 20871260 Free PMC article.
Bonney A, Malouf R, Marchal C, Manners D, Fong KM, Marshall HM, Irving LB, Manser R. Bonney A, et al. Cochrane Database Syst Rev. 2022 Aug 3;8(8):CD013829. doi: 10.1002/14651858.CD013829.pub2. Cochrane Database Syst Rev. 2022. PMID: 35921047 Free PMC article. Review.
Baldwin DR, Duffy SW, Wald NJ, Page R, Hansell DM, Field JK. Baldwin DR, et al. Thorax. 2011 Apr;66(4):308-13. doi: 10.1136/thx.2010.152066. Epub 2011 Feb 11. Thorax. 2011. PMID: 21317179 Free PMC article. Clinical Trial.
Mazzone PJ, Silvestri GA, Souter LH, Caverly TJ, Kanne JP, Katki HA, Wiener RS, Detterbeck FC. Mazzone PJ, et al. Chest. 2021 Nov;160(5):e427-e494. doi: 10.1016/j.chest.2021.06.063. Epub 2021 Jul 13. Chest. 2021. PMID: 34270968 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3